Intellia Therapeutics, Inc. (NTLA) vs Ocular Therapeutix, Inc. (OCUL)
- Intellia Therapeutics, Inc. NTLA 11.42 +0.71%
- Ocular Therapeutix, Inc. OCUL 6.87 −6.91%
Intellia Therapeutics, Inc. and Ocular Therapeutix, Inc. are both Biotechnology companies. Intellia Therapeutics, Inc. and Ocular Therapeutix, Inc. are of similar size ($1.6B and $1.6B). Intellia Therapeutics, Inc. grew revenue faster over the last twelve months: 12.6% against −8.14%. Ocular Therapeutix, Inc. has the higher net margin (−579.1% vs −672.2%) and the higher return on invested capital (0.00% vs −91.3%). Across the 18 metrics below, Intellia Therapeutics, Inc. leads on 10 and Ocular Therapeutix, Inc. on 8.
Valuation
Profitability
| Metric | NTLA | OCUL | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 87.11% | 65.16% |
| Operating margin | (711.66%) | (603.04%) | 0.00% |
| Net margin | (672.16%) | (579.10%) | 0.00% |
| Free cash flow margin | (585.82%) | (490.07%) | 0.00% |
| Return on equity | (55.44%) | (72.99%) | (56.36%) |
| Return on assets | (45.55%) | (53.70%) | (48.04%) |
| Return on invested capital | (91.28%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack